Martin Felices

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 18

Top Topics

Acute Myeloid Leukemia

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal for immunotherapy of cancer

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Anders W Matson, Rob Hullsiek, Kate J Dixon, Sam Wang, Anders J Lindstedt, Ryan R Friess, Shee Kwan Phung, Tanya S Freedman, Martin Felices, Emily N Truckenbrod, Jianming Wu, Jeffrey S Miller, Bruce Walcheck
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells. Journal for immunotherapy of cancer 12 (7) (2024)
Anders W Matson, Rob Hullsiek, Kate J Dixon, Sam Wang, Anders J Lindstedt, Ryan R Friess, Shee Kwan Phung, Tanya S Freedman, Martin Felices, Emily N Truckenbrod, Jianming Wu, Jeffrey S Miller, Bruce Walcheck
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells. Journal for immunotherapy of cancer 12 (7) (2024)
Anders W Matson, Rob Hullsiek, Kate J Dixon, Sam Wang, Anders J Lindstedt, Ryan R Friess, Shee Kwan Phung, Tanya S Freedman, Martin Felices, Emily N Truckenbrod, Jianming Wu, Jeffrey S Miller, Bruce Walcheck
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells. Journal for immunotherapy of cancer 12 (7) (2024)
Martin Felices, Erin Wesley, Laura E Bendzick, Behiye Kodal, Rachel Hopps, Bartosz J Grzywacz, Peter Hinderlie, Jeffrey S Miller, Melissa A Geller
Reverse translation identifies the synergistic role of immune checkpoint blockade and IL-15 to enhance immunotherapy of ovarian cancer. Cancer immunology research (2023)
Shernan G Holtan, Constanza Savid-Frontera, Kelly Walton, Anne A Eaton, Connor Demorest, Andrea Hoeschen, Ling Zhang, Kayla M Reid, Tony Kurian, Zena Sayegh, Estefania Julia, Joseph E Maakaron, Veronika Bachanova, Najla El Jurdi, Margaret L MacMillan, Daniel J Weisdorf, Martin Felices, Jeffrey S Miller, Bruce R Blazar, Marco L Davila, Brian C Betts
Human effectors of acute and chronic GVHD overexpress CD83 and predict mortality. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Shernan G Holtan, Constanza Savid-Frontera, Kelly Walton, Anne A Eaton, Connor Demorest, Andrea Hoeschen, Ling Zhang, Kayla M Reid, Tony Kurian, Zena Sayegh, Estefania Julia, Joseph E Maakaron, Veronika Bachanova, Najla El Jurdi, Margaret L MacMillan, Daniel J Weisdorf, Martin Felices, Jeffrey S Miller, Bruce R Blazar, Marco L Davila, Brian C Betts
Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Shernan G Holtan, Constanza Savid-Frontera, Kelly Walton, Anne A Eaton, Connor Demorest, Andrea Hoeschen, Ling Zhang, Kayla M Reid, Tony Kurian, Zena Sayegh, Estefania Julia, Joseph E Maakaron, Veronika Bachanova, Najla El Jurdi, Margaret L MacMillan, Daniel J Weisdorf, Martin Felices, Jeffrey S Miller, Bruce R Blazar, Marco L Davila, Brian C Betts
Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Shernan G Holtan, Constanza Savid-Frontera, Kelly Walton, Anne A Eaton, Connor Demorest, Andrea Hoeschen, Ling Zhang, Kayla M Reid, Tony Kurian, Zena Sayegh, Estefania Julia, Joseph E Maakaron, Veronika Bachanova, Najla El Jurdi, Margaret L MacMillan, Daniel J Weisdorf, Martin Felices, Jeffrey S Miller, Bruce R Blazar, Marco L Davila, Brian C Betts
Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
Shernan G Holtan, Constanza Savid-Frontera, Kelly Walton, Anne A Eaton, Connor Demorest, Andrea Hoeschen, Ling Zhang, Kayla M Reid, Tony Kurian, Zena Sayegh, Estefania Julia, Joseph E Maakaron, Veronika Bachanova, Najla El Jurdi, Margaret L MacMillan, Daniel J Weisdorf, Martin Felices, Jeffrey S Miller, Bruce R Blazar, Marco L Davila, Brian C Betts
Human effectors of acute and chronic GVHD overexpress CD83 and predict mortality. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Shernan G Holtan, Constanza Savid-Frontera, Kelly Walton, Anne A Eaton, Connor Demorest, Andrea Hoeschen, Ling Zhang, Kayla M Reid, Tony Kurian, Zena Sayegh, Estefania Julia, Joseph E Maakaron, Veronika Bachanova, Najla El Jurdi, Margaret L MacMillan, Daniel J Weisdorf, Martin Felices, Jeffrey S Miller, Bruce R Blazar, Marco L Davila, Brian C Betts
Human Effectors of Acute and Chronic GVHD Overexpress CD83 and Predict Mortality. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (6) (2023)
James D Dahlvang, Jenna Kelly Dick, Jules A Sangala, Philippa R Kennedy, Emily J Pomeroy, Kristin M Snyder, Juliette M Moushon, Claire E Thefaine, Jianming Wu, Sara E Hamilton, Martin Felices, Jeffrey S Miller, Bruce Walcheck, Beau R Webber, Branden S Moriarity, Geoffrey Thomas Hart
Ablation of SYK Kinase from Expanded Primary Human NK Cells via CRISPR/Cas9 Enhances Cytotoxicity and Cytokine Production. Journal of immunology (Baltimore, Md. : 1950) (2023)
Michael F Kaminski, Laura Bendzick, Rachel Hopps, Marissa Kauffman, Behiye Kodal, Yvette Soignier, Peter Hinderlie, Joshua T Walker, Todd R Lenvik, Melissa A Geller, Jeffrey S Miller, Martin Felices
TEM8 Tri-specific Killer Engager binds both tumor and tumor stroma to specifically engage natural killer cell anti-tumor activity. Journal for immunotherapy of cancer 10 (9) (2022)
Alvaro Haroun-Izquierdo, Marianna Vincenti, Herman Netskar, Hanna van Ooijen, Bin Zhang, Laura Bendzick, Minoru Kanaya, Pouria Momayyezi, Shuo Li, Merete Thune Wiiger, Hanna Julie Hoel, Silje Zandstra Krokeide, Veronika Kremer, Geir Tjonnfjord, Stéphanie Berggren, Kristina Wikström, Pontus Blomberg, Evren Alici, Martin Felices, Björn Önfelt, Petter Höglund, Bahram Valamehr, Hans-Gustaf Ljunggren, Andreas Björklund, Quirin Hammer, Lise Kveberg, Frank Cichocki, Jeffrey S Miller, Karl-Johan Malmberg, Ebba Sohlberg
Adaptive single-KIR + NKG2C + NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia. Journal for immunotherapy of cancer 10 (11) (2022)
Shee Kwan Phung, Jeffrey S Miller, Martin Felices
Bi-specific and Tri-specific NK Cell Engagers: The New Avenue of Targeted NK Cell Immunotherapy. Molecular diagnosis & therapy 25 (5) (2021)
Martin Felices, Jeffrey S Miller
Putting On the Gas and Taking Off the Brakes: A Novel Combinatorial Strategy to Enhance Tumor-Infiltrating Lymphocytes. Cancer immunology research 9 (10) (2021)
Martin Felices, Todd R Lenvik, Behiye Kodal, Peter Hinderlie, Laura E Bendzick, Dawn K Schirm, Michael F Kaminski, Ron T McElmurry, Melissa A Geller, Craig E Eckfeldt, Daniel A Vallera, Jeffrey S Miller
Potent Cytolytic Activity and Specific IL15 Delivery in a Second-Generation Trispecific Killer Engager. Cancer immunology research 8 (9) (2020)
Martin Felices, Behiye Kodal, Peter Hinderlie, Michael F Kaminski, Sarah Cooley, Daniel J Weisdorf, Daniel A Vallera, Jeffrey S Miller, Veronika Bachanova
Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL. Blood advances 3 (6) (2020)
Martin Felices, Jeffrey S Miller
NK cells pave the road for alloengraftment. Blood 127 (9) (2016)